Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum

Synthetic glucocorticoids (sGCs) such as dexamethasone (DEX), while used to mitigate inflammation and disease progression in premature infants with severe bronchopulmonary dysplasia (BPD), are also associated with significant adverse neurologic effects such as reductions in myelination and abnormali...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Juliann D. Jaumotte, Alexis L. Franks, Erin M. Bargerstock, Edwina Philip Kisanga, Heather L. Menden, Alexis Ghersi, Mahmoud Omar, Liping Wang, Anthony Rudine, Kelly L. Short, Neerupama Silswal, Timothy J. Cole, Venkatesh Sampath, A. Paula Monaghan-Nichols, Donald B. DeFranco
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2021-08-01
سلاسل:	Neurobiology of Disease
الموضوعات:	Ciclesonide Dexamethasone Bronchopulmonary dysplasia Glucocorticoids
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S0969996121001716
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!